Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: Journal of Medical Internet Research

Date Submitted: Nov 4, 2018
Open Peer Review Period: Nov 4, 2018 - Dec 5, 2018
Date Accepted: Dec 21, 2018
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial

Sato D, Yoshinaga N, Nagai E, Nagai K, Shimizu E

Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial

J Med Internet Res 2019;21(4):e12686

DOI: 10.2196/12686

PMID: 30973344

PMCID: 6482403

Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients with Insomnia Who Remain Symptomatic Following Pharmacotherapy: A Randomized Controlled Exploratory Trial

  • Daisuke Sato; 
  • Naoki Yoshinaga; 
  • Eiichi Nagai; 
  • Kazue Nagai; 
  • Eiji Shimizu

ABSTRACT

Background:

In reality, pharmacotherapy still remains the most common treatment for insomnia. This study aimed to examine the effectiveness of our internet delivered computerized cognitive behavioral therapy (ICBT) program as an adjunct to usual care (UC) compared with UC alone in patients with insomnia, who remain symptomatic following hypnotics.

Objective:

We examined the effectiveness of our ICBT program as an adjunct to UC compared with UC alone in patients with insomnia who remain symptomatic following hypnotics.

Methods:

We recruited 23 patients with insomnia who remain symptomatic following pharmacologic treatment including benzodiazepines, and we conducted a exploratory randomized controlled trial. The primary outcome was the Pittsburgh Sleep Quality Index (PSQI) at week 6 of treatment. Secondary outcomes were the sleep onset latency (SOL), total sleep time (TST), sleep efficiency (SE), number of awakenings (NA), refreshment and soundness of sleep, anxiety by Hospital Anxiety and Depression Scale (HADS), depression measured by the Center for Epidemiologic Studies Depression Scale (CES-D), and quality of life measured by the EuroQol-5D (EQ-5D). All parameters were measured at weeks 0 (baseline), 6 (post-intervention), and 12 (follow-up).

Results:

The adjusted mean reduction (−6.11) in PSQI at week 6 from baseline in the ICBT+UC group was significantly (p<0.001) larger than that (0.40) in the UC group. Significant differences were also found in favor of ICBT+UC for PSQI, SOL, SE, NA and depression at all assessment points. Refreshment, soundness of sleep, anxiety, and quality of life improved by week 6 in ICBT+UC compared with UC. There were no reports of adverse events in either group during the study.

Conclusions:

These results indicate that our 6-week ICBT program is an effective treatment adjunct to UC for improving insomnia and related symptoms even after unsuccessful pharmacotherapy. Clinical Trial: UMIN000021509. Trial name: Effectiveness study of internet-based cognitive behavioral therapy for insomnia: A pilot randomized controlled trial. URL: https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr_view.cgi?recptno=R000023545


 Citation

Please cite as:

Sato D, Yoshinaga N, Nagai E, Nagai K, Shimizu E

Effectiveness of Internet-Delivered Computerized Cognitive Behavioral Therapy for Patients With Insomnia Who Remain Symptomatic Following Pharmacotherapy: Randomized Controlled Exploratory Trial

J Med Internet Res 2019;21(4):e12686

DOI: 10.2196/12686

PMID: 30973344

PMCID: 6482403

Download PDF


Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.